BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/5/2026 10:47:27 AM | Browse: 12 | Download: 0
| Category |
Transplantation |
| Manuscript Type |
Review |
| Article Title |
Kidney transplantation in systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis: Challenges and clinical perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tabassum Elahi, Saima Ahmed and Muhammed Mubarak |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Muhammed Mubarak, Department of Histopathology, Sindh Institute of Urology and Transplantation, Chand Bibi Road, Karachi 74200, Sindh, Pakistan. drmubaraksiut@yahoo.com |
| Key Words |
Autoimmune kidney diseases; End-stage kidney disease; Kidney transplantation; Lupus nephritis; Recurrence risk; Systemic lupus erythematosus; Vasculitis |
| Core Tip |
Autoimmune kidney diseases such as lupus nephritis (LN) and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis are the major cause of end-stage kidney disease. Kidney transplantation (KT) is an important therapeutic option for these patients. Disease quiescence before transplantation is crucial in patients with LN. Novel biomarkers such as monocyte chemoattractant protein-1, B-cell activating factor, and matrix metalloproteinase-7 help in predicting the post-transplant recurrence. Outcomes may improve with preemptive KT and individualized immunosuppression. In ANCA-associated vasculitis, 12 months of stable remission is recommended, despite the presence of ANCA positivity. The relapse risk is minimized with advanced immunosuppressive regimens, while for post-transplant recurrence, rituximab offers an option. For optimizing long-term graft survival, modifying strategies and emerging cell-based therapies hold promise. |
| Citation |
Elahi T, Ahmed S, Mubarak M. Kidney transplantation in systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis: Challenges and clinical perspectives. World J Nephrol 2026; In press
|
| PDF |
123149-in-press.pdf
|
 |
Received |
|
2026-05-18 07:41 |
 |
Peer-Review Started |
|
2026-05-18 07:42 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2026-06-29 06:02 |
 |
Revised |
|
2026-07-11 11:52 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-08-05 03:18 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-08-05 10:47 |
 |
Articles in Press |
|
2026-08-05 10:47 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.